How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical-grade Cobalt-60 Market
- By Source Activity Level: Low Activity Sources, Medium Activity Sources, High Activity Sources
- By Application: Radiotherapy, Sterilization of Medical Equipment, Food Irradiation, Industrial Radiography, Research and Development
- By Product Form: Sealed Sources, Unsealed Sources
- By End User: Hospitals and Cancer Treatment Centers, Sterilization Facilities, Pharmaceutical Manufacturers, Research Laboratories
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Low Activity Sources leads By Source Activity Level at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 256 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.160 →
- 11 Company Profiles 10 players: SWOT & benchmarking p.168 →
Full report · locked preview
Everything inside the Medical-grade Cobalt-60 Market report
A complete, evidence-based study - 11 chapters and 107 sections covering market size, segmentation across 4 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Source Activity Level 3
Application 5
Product Form 2
End User 4
Companies profiled
Nordion (a Sotera Health company)
Best Theratronics Ltd.
MDS Nordion
Eckert & Ziegler BEBIG
Isotope Products Laboratories (IPL)
Cobalt-60 India Limited
China Isotope & Radiation Corporation (CIRC)
Nuclear Fields Inc.
AECL (Atomic Energy of Canada Limited)
Institute of Isotopes Co. Ltd. (Hungary)
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Nordion (a Sotera Health company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Best Theratronics Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →MDS Nordion
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Eckert & Ziegler BEBIG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Isotope Products Laboratories (IPL)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Cobalt-60 India Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →China Isotope & Radiation Corporation (CIRC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nuclear Fields Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →AECL (Atomic Energy of Canada Limited)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Institute of Isotopes Co. Ltd. (Hungary)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,775M by 2033 · 5.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Low Activity Sources45.7
- Medium Activity Sources27.3
- High Activity Sources27.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,040M → $1,694M · 6.3%
Europe$724.9M → $1,218M · 6.7%
Asia Pacific$661.8M → $1,038M · 5.8%
Latin America$409.7M → $645.3M · 5.8%
Middle East and Africa$315.2M → $532.6M · 6.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.282026
5.292027
5.302028
5.322029
5.342030
5.342031
5.362032
5.362033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Nordion (a Sotera Health company)23.3
- Best Theratronics Ltd.8.8
- MDS Nordion6.1
- Eckert & Ziegler BEBIG12.9
- Isotope Products Laboratories (IPL)9.2
- Cobalt-60 India Limited11.8
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Activity Level31.8%
Application23.1%
Product Form19.3%
End User25.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.0
- Europe23.8
- Asia Pacific20.2
- Latin America12.6
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Nordion (a Sotera Health company) | 76 | 88 | 90 | 87 | 77 | 92 | 85 |
| Best Theratronics Ltd. | 83 | 91 | 71 | 84 | 73 | 85 | 81 |
| MDS Nordion | 81 | 87 | 73 | 81 | 84 | 71 | 80 |
| Eckert & Ziegler BEBIG | 69 | 67 | 63 | 71 | 81 | 68 | 70 |
| Isotope Products Laboratories (IPL) | 71 | 70 | 57 | 71 | 52 | 70 | 65 |
| Cobalt-60 India Limited | 68 | 53 | 70 | 65 | 69 | 55 | 63 |
| China Isotope & Radiation Corporation (CIRC) | 61 | 47 | 47 | 44 | 49 | 43 | 49 |
| Nuclear Fields Inc. | 50 | 37 | 47 | 38 | 56 | 40 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Nordion (a Sotera Health company)
- Best Theratronics Ltd.
- MDS Nordion
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Nordion (a Sotera Health company) | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Best Theratronics Ltd. | ✓ | ◐ | ◐ | ◐ | − | ✓ |
| MDS Nordion | ◐ | ✓ | ◐ | ✓ | ✓ | − |
| Eckert & Ziegler BEBIG | − | ◐ | ◐ | ✓ | ◐ | ◐ |
| Isotope Products Laboratories (IPL) | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Cobalt-60 India Limited | ◐ | − | ◐ | ◐ | ◐ | − |
| China Isotope & Radiation Corporation (CIRC) | − | − | − | ◐ | − | − |
| Nuclear Fields Inc. | ◐ | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nordion (a Sotera Health company)85
2Best Theratronics Ltd.81
3MDS Nordion80
4Eckert & Ziegler BEBIG70
5Isotope Products Laboratories (IPL)65
6Cobalt-60 India Limited63
7China Isotope & Radiation Corporation (CIRC)49
8Nuclear Fields Inc.45
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Nordion (a Sotera Health company)Best Theratronics Ltd.MDS Nordion
Challenger1
Strong scale, closing on the leaders.
Eckert & Ziegler BEBIG
Contender2
Focused players with pockets of strength.
Isotope Products Laboratories (IPL)Cobalt-60 India Limited
Niche2
Specialists in a single segment or region.
China Isotope & Radiation Corporation (CIRC)Nuclear Fields Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Activity Level in North America, then scale across Medical-grade Cobalt-60 Market — a $547M beachhead inside a $8.79B market.
Beachhead (SOM)$547Mobtainable near-term
Serviceable (SAM)$3.30Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Low Activity Sources
Best fit — highest urgency & budget in Source Activity Level.
Economic buyer78 fit
Medium Activity Sources
Strong fit — clear ROI and a fast path to value.
End user65 fit
High Activity Sources
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Activity Level in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Product Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Source Activity Level leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical-grade Cobalt-60 Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation13%
Closed-won5%
$9.1KCAC
$51KLTV
5.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical-grade Cobalt-60 Market is a durable-growth opportunity — $6.33B by 2033, compounding at 8.6%.
TAM · 2025$3.28Btoday
TAM · 2033$6.33Bforecast
CAGR8.6%2027–2033
Cumulative$41.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.33BTotal addressable market
SAM$2.19BServiceable available market
SOM$415MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Source Activity Level.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Activity Level moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.33BLarge & growingTAM by 2033 at 8.6% CAGR
$2.19BServiceable nowreachable with today’s model
$415MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.93BBear5.6% CAGR
$6.33BBase8.6% CAGR
$8.10BBull11.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical-grade Cobalt-60 Market — a $4.99B market by 2033. Plan: grow share from 9.5% to 18.9%.
Market size · 2033$4.99Btotal addressable
Market CAGR3.7%2027–2033
Target share18.9%from 9.5% today
Revenue ambition$943Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.5% | 18.9% | Ahead |
| Revenue | $470M | $943M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 37.4% | 43.8% | Behind |
| Customer retention | 91.1% | 92.2% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Activity Level
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Activity Level share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $129M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Source Activity Level leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical-grade Cobalt-60 Market conversation — a $8.80B market you can size, segment and defend in minutes.
Market size · 2033$8.80Btotal opportunity
Growth6.7%CAGR to 2033
Addressable buyers952+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Activity Level
Goal Grow share in Source Activity Level
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 3 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
Nordion (a Sotera Health company)Best Theratronics Ltd.MDS NordionEckert & Ziegler BEBIGIsotope Products Laboratories (IPL)Cobalt-60 India LimitedChina Isotope & Radiation Corporation (CIRC)Nuclear Fields Inc.+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical-grade Cobalt-60 Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical-grade Cobalt-60 Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Medical Grade CO2 Absorbent Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportMedical Grade CMOS Image Sensor Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportMedical Grade Chitosan Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportMedical-grade Chitin Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportMedical Grade Cart Computer Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportMedical Grade Carbomer Market
Market size, share, segmentation and regional forecast.
$675M market · 2025 base year
View reportMedical Grade Camera Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportMedical Grade Cable Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportMedical Grade Braid Reinforced Hose Market
Market size, share, segmentation and regional forecast.
$625M market · 2025 base year
View reportMedical Grade Box PC Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportMedical Grade Back-illuminated CMOS Image Sensor Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportMedical Grade Alloy Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.